Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €41.99 EUR
Change Today -0.08 / -0.19%
Volume 15.9K
GIMB On Other Exchanges
EN Brussels
As of 11:35 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

gimv nv (GIMB) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/3/15 - €45.25
52 Week Low
10/16/14 - €34.16
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GIMV NV (GIMB)

Related News

No related news articles were found.

gimv nv (GIMB) Related Businessweek News

No Related Businessweek News Found

gimv nv (GIMB) Details

GIMV NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, replacement capital, bridge financing, recapitalization, and PIPES. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer 2020; health and care; smart industries; and sustainable cities. Within consumer 2020, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. It mainly focuses on European market and midcap companies in Flanders and Brussels, and also invests in Kazakhstan, Benelux, Germany, France, Italy, Luxembourg, Netherlands, United Kingdom, Russia, Czech Republic, and Slovakia. Within consumer 2020, it focuses on consumer goods, food and beverage, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. It invests in small and medium sized businesses primarily with headquarters in the Benelux, France, and Germany with an enterprise value of up to €125 million ($144.76 million). It seeks to invest between €3 million ($3.47 million) to €30 million ($34.74 million). Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services based companies with headquarters in Benelux, France and Germany (DACH). It typically makes investments between €3 million ($3.47 million) to €10 million ($11.58 million) in the biopharma and medtech and between €10 million ($11.58 million) to €30 million ($34.74 million) in the health and care services. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced computation power, and components and systems for efficient use of energy, in terms of production, storage, management, use and transport sectors. It focuses on B2B products and services, based on innovation, advanced engineering or software. It seeks to invest in small to medium companies with headquarters in the Benelux, France and Germany (DACH) targeting an international customer base. It invests in companies with an enterprise value of up to €125 million ($144.76 million). It also makes flexible equity investment (equity, semi-equity, minority or majority) but always with a meaningful impact on the company and an exit trigger. It seeks to invest between €3 million ($3.47 million) to €30 million ($34.74 million). Within sustainable cities, it focuses on Products, services and infrastructure for building sustainable urban societies: Utilities and consumer goods related to energy and other (raw) materials, Waste treatment, recycling and recovery, Construction and Infrastructure, Transport and Logistics Services, and biomass, green (= sustainable) chemistry, water, offshore and maritime solutions and energy efficient infrastructure. It invests through (mezzanine, equity, minority or majority) but will always strive to have a meaningful impact on the company strategy and need an exit trigger. It also invests in semiconductors, chemicals, agriculture, clean technology, electronics, water processing and purification technologies. For fund of fund investments, it seeks to invest in Europe. It typically invests between $3.73 million and $425.439 million in companies with an enterprise value between $106.04 million and $1060.44 million and sales value ranging from $6.67 million to $567.252 million. It may take a majority or a minority stake in its portfolio companies. Its investment horizon is between four and seven years. It also seeks a board seat in its portfolio companies. It invests with capital from its own balance sheet and through various funds under management. GIMV NV was founded on February 25, 1980 and is based in Antwerp, Belgium with additional offices in Paris, France; Netherlands, The Netherlands; Frankfurt am Main, Germany; London, United Kingdom; Prague, Czech Republic; Warsaw, Poland; and Munich, Germany.

Founded in 1980

gimv nv (GIMB) Top Compensated Officers

Chief Executive Officer, Managing Director an...
Total Annual Compensation: €569.9K
Compensation as of Fiscal Year 2015.

gimv nv (GIMB) Key Developments

Gimv Approves Gross Dividend for the Fiscal Year 2015, Payable on July 1, 2015; Announces Board Appointments

Gimv approved the payment of gross dividend of EUR 2.45 per share for the financial year 2014-2015, payable on July 1, 2015. Ex-date of dividend payment is June 29, 2015. Record date of dividend is June 30, 2015. The company approved the appointment of following new directors: Ms. Brigitte Boone (until 2019), Ms. Hilde Laga (until 2019) and Mr. Karel Plasman (until 2019).

Gimv Proposes Gross Dividend for 2014-2015, Payable on July 1, 2015; Announces Consolidated Earnings Results for the Full Year Ended March 31, 2015

The board of Gimv decided in May 2015 to propose to the annual general meeting of June 24, 2015 to pay an unchanged gross dividend of EUR 2.45 per share. Record date of the 2014-2015 dividend is June 30, 2015. If the general meeting approves this dividend proposal, the dividend will be paid out on July 1, 2015. Ex-date of the 2014-2015 dividend is June 29, 2015. The company announced consolidated earnings results for the full year ended March 31, 2015. For the year, the company reported operating income of EUR 278,763,000 compared with EUR 159,056,000 for the same period a year ago. Operating profit was EUR 143,883,000 compared with EUR 12,494,000 for the same period a year ago. Profit before tax was EUR 146,544,000 compared with EUR 16,934,000 for the same period a year ago. Net profit of the period attributable to equity holders of the parent was EUR 135,991,000 or EUR 5.35 per basic and diluted share compared with EUR 14,998,000 or EUR 0.61 per basic and diluted share for the same period a year ago. Net cash provided by operating activities was EUR 193,568,000 compared with net cash used in operating activities of EUR 94,606,000 for the same period a year ago. Purchase of property, plant and equipment was EUR 810,000 compared with EUR 939,000 for the same period a year ago.

GIMV NV Presents at BIO-Europe Spring 2015, Mar-09-2015

GIMV NV Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GIMB:BB €41.99 EUR -0.08

GIMB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GIMB.
View Industry Companies

Industry Analysis


Industry Average

Valuation GIMB Industry Range
Price/Earnings 8.0x
Price/Sales 3.9x
Price/Book 1.0x
Price/Cash Flow 8.0x
TEV/Sales 3.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GIMV NV, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at